Aion Therapeutic Inc

Aion Therapeutic, Inc. engages in providing medical cannabis services. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-02-21. The firm offers various formulations which help with obesity, viral diseases, inflammation, mental health, and cancer. The company has developed novel compositions and methods useful for promoting weight loss and in the treatment of obesity. These nutraceutical and pharmaceutical compositions comprise mushrooms or their extracts, cannabis extracts, terpenes, flavonoids, and other botanicals with known health benefits. Its inflammation formulations are applicable to both chronic and acute inflammation. Its Mental Health formulations use AI to create optimized compositions and methods useful in the treatment of psychotic disorders including depression, anxiety, PTSD, addictions and substance abuse, and related psychological conditions. Its cancer formulations are able to target multiple types of cancer based on AI-optimized compositions that are both cancer-type specific and patient-specific.